4.6 Article

Lacticaseibacillus rhamnosus-Derived Exopolysaccharide Attenuates D-Galactose-Induced Oxidative Stress and Inflammatory Brain Injury and Modulates Gut Microbiota in a Mouse Model

期刊

MICROORGANISMS
卷 10, 期 10, 页码 -

出版社

MDPI
DOI: 10.3390/microorganisms10102046

关键词

exopolysaccharide; antioxidant; anti-inflammatory; gut microbiota; microbiota-gut-brain axis

资金

  1. National Centre on Veterinary Type Cultures (NCVTC), Hissar (India)
  2. Ministry of Food Processing Industries, Government of India [Q-11/40/2018-RD]

向作者/读者索取更多资源

This study found that the novel exopolysaccharide EPSRam12 produced by Lacticaseibacillus rhamnosus Ram12 has a protective effect against D-galactose-induced brain injury and gut microbiota dysbiosis in mice. EPSRam12 increases antioxidant enzymes and anti-inflammatory cytokines in the brain, while improving gut mucosal barrier function and increasing short-chain fatty acids levels in the intestine. It also restores gut microbial diversity by enriching beneficial microbial genera and decreasing pathogenic bacteria.
This study aimed to investigate the protective effect of a novel exopolysaccharide EPSRam12, produced by Lacticaseibacillus rhamnosus Ram12, against D-galactose-induced brain injury and gut microbiota dysbiosis in mice. The findings demonstrate that EPSRam12 increases the level of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase, total antioxidant capacity, and the level of anti-inflammatory cytokine IL-10, while decreasing malonaldehyde, nitric oxide, pro-inflammatory cytokines including TNF-alpha, IL-1 beta, IL-6, MCP-1, and the mRNA expression of cyclooxygenase-2, inducible nitric oxide synthase, and the activation of nuclear factor-kappa-B in the brain tissues of D-galactose-treated mice. Further analyses reveal that EPSRam12 improves gut mucosal barrier function and increases the levels of short-chain fatty acids (SCFAs) in the intestine while restoring gut microbial diversity by enriching the abundance of SCFA-producing microbial genera Prevotella, Clostridium, Intestinimonas, and Acetatifactor while decreasing potential pathobionts including Helicobacter. These findings of antioxidative and anti-inflammatory effects in the brain and ameliorative effects on epithelial integrity, SCFAs and microbiota in the gut, provide novel insights into the effect of EPSRam12 intervention on the gut-microbiome-brain axis and should facilitate prospective understanding of microbial exopolysaccharide for improved host health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据